Page 43 - 2023 Taiwan Food and Drug Administration Annual Report
P. 43
3
Advancement of Drug
Management
TFDA continues to construct a robust Section 1
regulatory environment and harmonizes
with international standards throughout the Normalization of
life cycle of medicinal products through Drug Management
improved regulations of medicinal product Regulations
distribution, digitalized management, the
supervision of quality and safety, and the ▍ Introduction of the Policy
inspection technology for quality, among
others, to effectively ensure the safety, In order to cope with the development
efficacy, and quality for medicinal products, trends around the world and to increase
to provide the general public with a safe the accessibility of medicinal products,
environment for medicinal products usages TFDA constantly refers to the international
as well as facilitate the development of the regulations of regenerative medicinal
domestic pharmaceutical industry. TFDA products, the regulation of intellectual
also strengthens the medical exchange and property rights, as well as cooperating
cooperation with the new south-bound with the current development status of
countries through our experience gained the domestic pharmaceutical industry, we
a long-term commitment to establishing continue improving the relevant regulations
an international pharmaceutical regulation and providing a better medicinal product
environment and the relevant industry regulatory environment.
advantages.
41
